FT
EU bets on BioNTech/Pfizer jab as Danes end use of AstraZeneca
Brussels puts focus on mRNA vaccines amid concern over rare blood clots linked to other shots
Brussels puts focus on mRNA vaccines amid concern over rare blood clots linked to other shots